About the Authors
- Harri Lempiäinen
-
Contributed equally to this work with: Harri Lempiäinen, Arne Müller
Affiliation Investigative Toxicology, Preclinical Safety, Translational Sciences, Novartis Institutes for Biomedical Research, Basel, Switzerland
- Arne Müller
-
Contributed equally to this work with: Harri Lempiäinen, Arne Müller
Affiliation Investigative Toxicology, Preclinical Safety, Translational Sciences, Novartis Institutes for Biomedical Research, Basel, Switzerland
- Sarah Brasa
-
Affiliation Investigative Toxicology, Preclinical Safety, Translational Sciences, Novartis Institutes for Biomedical Research, Basel, Switzerland
- Soon-Siong Teo
-
Affiliation Investigative Toxicology, Preclinical Safety, Translational Sciences, Novartis Institutes for Biomedical Research, Basel, Switzerland
- Tim-Christoph Roloff
-
Affiliation Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland
- Laurent Morawiec
-
Affiliation Investigative Toxicology, Preclinical Safety, Translational Sciences, Novartis Institutes for Biomedical Research, Basel, Switzerland
- Natasa Zamurovic
-
Affiliation Investigative Toxicology, Preclinical Safety, Translational Sciences, Novartis Institutes for Biomedical Research, Basel, Switzerland
- Axel Vicart
-
Affiliation Investigative Toxicology, Preclinical Safety, Translational Sciences, Novartis Institutes for Biomedical Research, Basel, Switzerland
- Enrico Funhoff
-
Affiliation Investigative Toxicology, Preclinical Safety, Translational Sciences, Novartis Institutes for Biomedical Research, Basel, Switzerland
- Philippe Couttet
-
Affiliation Investigative Toxicology, Preclinical Safety, Translational Sciences, Novartis Institutes for Biomedical Research, Basel, Switzerland
- Dirk Schübeler
-
Affiliation Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland
- Olivier Grenet
-
Affiliation Investigative Toxicology, Preclinical Safety, Translational Sciences, Novartis Institutes for Biomedical Research, Basel, Switzerland
- Jennifer Marlowe
-
Affiliation Investigative Toxicology, Preclinical Safety, Translational Sciences, Novartis Institutes for Biomedical Research, Basel, Switzerland
- Jonathan Moggs
-
Affiliation Investigative Toxicology, Preclinical Safety, Translational Sciences, Novartis Institutes for Biomedical Research, Basel, Switzerland
- Rémi Terranova
-
* E-mail: remi.terranova@novartis.com
Affiliation Investigative Toxicology, Preclinical Safety, Translational Sciences, Novartis Institutes for Biomedical Research, Basel, Switzerland
Competing Interests
The authors have declared that no competing interests exist. All authors work for Novartis Institutes for Biomedical Research and confirm that this does not alter their adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: J. Marlowe J. Moggs OG RT HL EF NZ. Performed the experiments: HL SB S-ST LM AV. Analyzed the data: HL AM SB S-ST T-CR AV EF PC DS OG J. Marlowe J. Moggs RT. Contributed reagents/materials/analysis tools: T-CR DS. Wrote the paper: RT AM EF HL J. Marlowe J. Moggs.